Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00790179

Enrollment

225

Registered

2008-11-13

Start date

2003-01-31

Completion date

2007-03-31

Last updated

2008-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Continuous lumbar plexus,Femoral,hydromorphone

Brief summary

Continuous lumbar plexus and femoral blocks have been demonstrated to provide effective postoperative analgesia of the lower extremity following total joint arthroplasty. The purpose of this study was to compare these two techniques when used with intravenous patient-controlled analgesia and the use of patient-controlled analgesia alone for postoperative pain management following unilateral total hip arthroplasty.

Detailed description

above may be applied

Interventions

PROCEDUREcontinuous infusion of ropivacaine via CLPB vs. CFB vs IV PCA

0.5% Ropivacaine bolus of 30 ml. followed by ropivacaine 0.2%at 10 ml/hr via CLPB vs. CFB. Hydromorphone 0.3 mg demand only every 10 minutes via IV PCA.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* 18-80 years old * primary diagnosis of osteoarthritis

Exclusion criteria

* allergy to local anesthetics * peripheral neuropathy * opioid dependency * dementia * coagulopathy

Design outcomes

Primary

Measure	Time frame
VAS pain scores	at 24 and 48 hours

Secondary

Measure	Time frame
hydromorphone consumption,patient satisfaction,distance ambulated, opioid-related side effects	at 24 and 48 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026